Breaking News Instant updates and real-time market news.

TODAY'S FREE FLY STORIES

Recommendations
Evelo Biosciences price target lowered to $17 from $21 at BMO Capital » 08:39
07/02/20
07/02
08:39
07/02/20
08:39
EVLO

Evelo Biosciences

$4.90 /

-0.05 (-1.01%)

BMO Capital analyst…

BMO Capital analyst Matthew Luchini lowered the firm's price target on Evelo Biosciences to $17 from $21 to reflect the dilution from the company's recent follow-on offering. The analyst still keeps an Outperform rating on the shares and sees the interim results from the company's ongoing Phase 1/2 open-label trial of EDP1503 plus Keytruda as "early but encouraging" given its 33% objective response rate, supporting further enrollment to assess the potential of the drug.

ShowHide Related Items >><<
EVLO Evelo Biosciences
$4.90 /

-0.05 (-1.01%)

EVLO Evelo Biosciences
$4.90 /

-0.05 (-1.01%)

05/21/20 Morgan Stanley
Morgan Stanley downgrades Evelo to Equal Weight after AD discontinuation
05/21/20 Morgan Stanley
Evelo Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
05/12/20 Jefferies
Evelo Biosciences downgraded to Hold from Buy at Jefferies
EVLO Evelo Biosciences
$4.90 /

-0.05 (-1.01%)

  • 25
    Jun
EVLO Evelo Biosciences
$4.90 /

-0.05 (-1.01%)

Recommendations
JPMorgan sees attractive opportunities in India for Cisco, Ciena » 08:36
07/02/20
07/02
08:36
07/02/20
08:36
CSCO

Cisco

$45.70 /

-0.58 (-1.25%)

The revenue opportunity…

The revenue opportunity for network equipment companies in India is relatively small in the global context, but it remains an attractive opportunity for Cisco Systems (CSCO) and Ciena CIEN), JPMorgan analyst Samik Chatterjee tells investors in a research note. The analyst sees an improving outlook for spending and market share prospects for U.S. networking equipment companies in India, led by recent investments from global companies in domestic telecom players, consolidation in the telecom industry improving underlying fundamentals, and restrictions in relation to use of Huawei equipment. Chatterjee sees opportunities for both Ciena and Cisco to drive "conquest wins" against Huawei. Ciena is positioned to benefit in optical and Cisco to benefit incrementally in switching and routing, says the analyst.

ShowHide Related Items >><<
CSCO Cisco
$45.70 /

-0.58 (-1.25%)

CSCO Cisco
$45.70 /

-0.58 (-1.25%)

06/16/20
Fly Intel: Top five analyst upgrades
06/16/20 BofA
Cisco upgraded to Buy from Neutral at BofA
06/16/20 BofA
Cisco upgraded to Buy from Neutral at BofA
06/10/20
Fly Intel: Top five analyst downgrades
CSCO Cisco
$45.70 /

-0.58 (-1.25%)

CSCO Cisco
$45.70 /

-0.58 (-1.25%)

CSCO Cisco
$45.70 /

-0.58 (-1.25%)

CSCO Cisco
$45.70 /

-0.58 (-1.25%)

Hot Stocks
Novavax appoints Frank Czworka as SVP, global sales » 08:36
07/02/20
07/02
08:36
07/02/20
08:36
NVAX

Novavax

$79.70 /

-3.69 (-4.42%)

Novavax announced the…

Novavax announced the appointment of Frank Czworka as SVP, Global Sales, with responsibility for leading sales planning and distribution. Novavax also announced the promotion of Brian Webb to SVP, Manufacturing, with responsibility for overseeing antigen manufacturing and supply activities in support of Novavax' vaccine candidates. Czworka brings more than two decades of biopharmaceutical experience to Novavax, most recently serving as VP, Global Customer Engagement at U.S. Pharmacopeia. Webb joined Novavax in May 2014 with responsibility for internal and external manufacturing.

ShowHide Related Items >><<
NVAX Novavax
$79.70 /

-3.69 (-4.42%)

NVAX Novavax
$79.70 /

-3.69 (-4.42%)

06/29/20 B. Riley FBR
Novavax price target raised to $106 from $74 at B. Riley FBR
06/29/20 H.C. Wainwright
Novavax price target raised to $101 from $50 at H.C. Wainwright
06/19/20 Cantor Fitzgerald
Novavax price target raised to $88 from $45 at Cantor Fitzgerald
06/05/20
Fly Intel: Top five analyst upgrades
NVAX Novavax
$79.70 /

-3.69 (-4.42%)

NVAX Novavax
$79.70 /

-3.69 (-4.42%)

NVAX Novavax
$79.70 /

-3.69 (-4.42%)

NVAX Novavax
$79.70 /

-3.69 (-4.42%)

Hot Stocks
BRP Group appoints Erin King as chief colleague officer » 08:33
07/02/20
07/02
08:33
07/02/20
08:33
BRP

BRP Group

$16.58 /

-0.7 (-4.05%)

BRP Group announced the…

BRP Group announced the appointment of Erin King as chief colleague officer.. As a key member of BRP Group's executive leadership team, King will continue to build and foster a culture focused on attracting, retaining and developing top talent. She joins the firm from Publix, an employee-owned retail grocer known for its exceptional customer service, where she served as Human Resources Director. In her new role as chief colleague officer, Ms. King will oversee such vital human resources areas as learning and development, talent acquisition and management, compensation and benefits strategy, rewards and recognition, and colleague relations.

ShowHide Related Items >><<
BRP BRP Group
$16.58 /

-0.7 (-4.05%)

BRP BRP Group
$16.58 /

-0.7 (-4.05%)

03/26/20 Keefe Bruyette
BRP Group price target lowered to $16 from $22 at Keefe Bruyette
02/21/20 Northcoast
BRP Group downgraded to Neutral from Buy at Northcoast
11/18/19
Fly Intel: Top five analyst initiations
11/18/19 Jefferies
BRP Group initiated with a Hold at Jefferies
BRP BRP Group
$16.58 /

-0.7 (-4.05%)

  • 25
    Jun
  • 24
    Oct
BRP BRP Group
$16.58 /

-0.7 (-4.05%)

General news
June U.S. nonfarm payrolls rise 4.8M, Unemployment rate drops to 11.1%  08:30
07/02/20
07/02
08:30
07/02/20
08:30
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$310.56 /

+2.11 (+0.68%)

 
ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPY SPDR S&P 500 ETF Trust
$310.56 /

+2.11 (+0.68%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$310.56 /

+2.11 (+0.68%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$310.56 /

+2.11 (+0.68%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Options
Three new option listings and five option delistings on July 2nd » 08:30
07/02/20
07/02
08:30
07/02/20
08:30
ACI

Albertsons

$15.80 /

+0.05 (+0.32%)

, CVIA

Covia

/

+

, GNC

GNC Holdings

/

+

, IBKC

Iberiabank

$43.02 /

-2.47 (-5.43%)

, MINI

Mobile Mini

$29.53 /

+ (+0.00%)

New option listings for…

New option listings for July 2nd include Albertsons Companies Inc (Class A Stock) (ACI), Covia Holdings Corp (CVIAQ), and GNC Holdings Inc (Class A Stock) (GNCIQ). Option delistings effective July 2nd include Covia Holdings (CVIA), GNC Holdings Inc (Class A Stock) (GNC), IBERIBANK Corporation (IBKC), Mobile Mini Inc (MINI), and Sanchez Energy Corporation (SNECQ).

ShowHide Related Items >><<
MINI Mobile Mini
$29.53 /

+ (+0.00%)

IBKC Iberiabank
$43.02 /

-2.47 (-5.43%)

GNC GNC Holdings
/

+

CVIA Covia
/

+

ACI Albertsons
$15.80 /

+0.05 (+0.32%)

ACI Albertsons
$15.80 /

+0.05 (+0.32%)

CVIA Covia
/

+

03/11/20 Tudor Pickering
Covia downgraded to Hold from Buy at Tudor Pickering
03/09/20 Evercore ISI
Covia downgraded to Underperform from In Line at Evercore ISI
08/13/19 Barclays
Barclays upgrades Covia to Equal Weight after 'very strong' quarter
08/13/19 Barclays
Covia upgraded to Equal Weight from Underweight at Barclays
GNC GNC Holdings
/

+

03/17/20 Jefferies
Jefferies cuts GNC Holdings to Underperform on risk from closures and debt
03/17/20 Jefferies
GNC Holdings downgraded to Underperform from Hold at Jefferies
IBKC Iberiabank
$43.02 /

-2.47 (-5.43%)

04/21/20 SunTrust
Iberiabank price target lowered to $44 from $54 at SunTrust
04/01/20 Keefe Bruyette
Iberiabank upgraded to Outperform from Market Perform at Keefe Bruyette
01/07/20 Jefferies
Iberiabank downgraded to Hold from Buy at Jefferies
11/06/19 Keefe Bruyette
Iberiabank downgraded to Market Perform from Outperform at Keefe Bruyette
MINI Mobile Mini
$29.53 /

+ (+0.00%)

06/10/20 Oppenheimer
Mobile Mini price target raised to $41 from $34 at Oppenheimer
04/23/20 Oppenheimer
Mobile Mini price target lowered to $34 from $47 at Oppenheimer
09/26/19 Deutsche Bank
WillScot acquisition of Mobile Mini would be well received, says Deutsche Bank
09/26/19 Jefferies
WillScot's reported acquisition looks value enhancing, says Jefferies
MINI Mobile Mini
$29.53 /

+ (+0.00%)

IBKC Iberiabank
$43.02 /

-2.47 (-5.43%)

GNC GNC Holdings
/

+

CVIA Covia
/

+

  • 26
    Jun
ACI Albertsons
$15.80 /

+0.05 (+0.32%)

ACI Albertsons
$15.80 /

+0.05 (+0.32%)

GNC GNC Holdings
/

+

Downgrade
FormFactor downgraded to Hold at Craig-Hallum » 08:29
07/02/20
07/02
08:29
07/02/20
08:29
FORM

FormFactor

$29.34 /

+0.01 (+0.03%)

As previously reported,…

As previously reported, Craig-Hallum analyst Christian Schwab downgraded FormFactor to Hold from Buy with a price target of $29, up from $25, as he believes the shares are fairly priced at current levels. Nonetheless, the analyst is encouraged by the limited impacts experienced from COVID-19 compared to what was originally feared and continues to believe the company is well positioned to benefit from node shrinks of leading foundry/logic customers, second half of the year volume ramps of next generation DRAM, as well as the coming 5G secular trend for the company's RF business.

ShowHide Related Items >><<
FORM FormFactor
$29.34 /

+0.01 (+0.03%)

FORM FormFactor
$29.34 /

+0.01 (+0.03%)

07/02/20 Craig-Hallum
FormFactor downgraded to Hold from Buy at Craig-Hallum
07/02/20 Stifel
FormFactor price target raised to $35 after positive pre-announcement at Stifel
06/18/20 B. Riley FBR
FormFactor price target raised to $36 from $30 at B. Riley FBR
06/15/20 Stifel
FormFactor upgraded to Buy from Hold at Stifel
FORM FormFactor
$29.34 /

+0.01 (+0.03%)

FORM FormFactor
$29.34 /

+0.01 (+0.03%)

Initiation
Rocket Pharmaceuticals initiated with an Overweight at JPMorgan » 08:26
07/02/20
07/02
08:26
07/02/20
08:26
RCKT

Rocket Pharmaceuticals

$20.50 /

-0.42 (-2.01%)

JPMorgan analyst Eric…

JPMorgan analyst Eric Joseph initiated coverage of Rocket Pharmaceuticals with an Overweight rating and $38 price target. The company is advancing a "differentiated" gene therapy platform that is well positioned against multiple rare pediatric diseases with either "first- or best-in-class product candidates," Joseph tells investors in a research note. Rocket's pipeline "boasts multiple shots on goal, the majority of which offering rapid timelines to commercialization," says the analyst.

ShowHide Related Items >><<
RCKT Rocket Pharmaceuticals
$20.50 /

-0.42 (-2.01%)

RCKT Rocket Pharmaceuticals
$20.50 /

-0.42 (-2.01%)

06/25/20 BofA
Rocket Pharmaceuticals reinstated with a Buy at BofA
06/25/20 BofA
Rocket Pharmaceuticals reinstated with a Buy at BofA
05/13/20 Piper Sandler
Rocket Pharmaceuticals programs look even more promising, says Piper Sandler
03/05/20 Piper Sandler
Piper sees 'substantial value' for Rocket from numerous trial readouts
RCKT Rocket Pharmaceuticals
$20.50 /

-0.42 (-2.01%)

  • 11
    Dec
Hot Stocks
WeedMD announces amendment to existing credit facility » 08:25
07/02/20
07/02
08:25
07/02/20
08:25
WDDMF

WeedMD

$0.00 /

+ (+0.00%)

WeedMD confirmx it has…

WeedMD confirmx it has signed an amendment to its senior secured credit facility entered into on March 29, 2019. The Credit Agreement Amendment modifies the terms of the Credit Facility under which WeedMD secured up to $39M of debt financing over a three-year term ending in 2022. Under the terms of the Credit Agreement Amendment, the Company secured a deferral of its financial covenants by 12 months to June 30, 2021, and quarterly principal repayments have been rescheduled to commence in the first quarter of 2021. In addition, the Company has agreed to a 50 basis point increase in the applicable interest rate margin on the Credit Facility.

ShowHide Related Items >><<
WDDMF WeedMD
$0.00 /

+ (+0.00%)

WDDMF WeedMD
$0.00 /

+ (+0.00%)

WDDMF WeedMD
$0.00 /

+ (+0.00%)

General news
Oil Action: WTI crude » 08:25
07/02/20
07/02
08:25
07/02/20
08:25

Oil Action: WTI crude is…

Oil Action: WTI crude is steady over the $40 mark in early trade. The contract had rallied overnight from a $39.48 low to highs of $40.41. Wednesday's large weekly EIA inventory drop has been supportive. Give the partial reversals of reopening in the U.S., given the sharp increases in new COVID cases, upside potential for oil prices would appear to be limited for now, as oil demand concerns are renewed. The trend high of $41.63 seen on on June 23 is the next upside target, with the 20-day moving average at $38.80 providing initial support.

Conference/Events
Dime Community and Bridge Bancorp hold a joint conference call » 08:25
07/02/20
07/02
08:25
07/02/20
08:25
BDGE

Bridge Bancorp

$21.86 /

-0.91 (-4.00%)

, DCOM

Dime Community

$12.87 /

-0.86 (-6.26%)

Dime Community and Bridge…

Dime Community and Bridge Bancorp hold a joint conference call to discuss their definitive merger agreement to combine both companies in an all-stock merger of equal transactions valued at ~$489M on July 2 at 8:30 am. Webcast Link

ShowHide Related Items >><<
DCOM Dime Community
$12.87 /

-0.86 (-6.26%)

BDGE Bridge Bancorp
$21.86 /

-0.91 (-4.00%)

BDGE Bridge Bancorp
$21.86 /

-0.91 (-4.00%)

09/26/19 DA Davidson
Bridge Bancorp initiated with a Neutral at DA Davidson
DCOM Dime Community
$12.87 /

-0.86 (-6.26%)

06/04/20
Dime Community raises $50M in a preferred stock offering
04/28/20 Piper Sandler
Dime Community downgraded to Neutral after Q1 results at Piper Sandler
04/28/20 Piper Sandler
Dime Community downgraded to Neutral from Overweight at Piper Sandler
03/19/20
Dime Community initiated with a Buy at DA Davidson
DCOM Dime Community
$12.87 /

-0.86 (-6.26%)

BDGE Bridge Bancorp
$21.86 /

-0.91 (-4.00%)

Conference/Events
Cboe Global Markets to host conference call » 08:25
07/02/20
07/02
08:25
07/02/20
08:25
CBOE

Cboe Global Markets

$96.41 /

+3.34 (+3.59%)

President and Chief…

President and Chief Executive Officer of Cboe Global Markets Tilly and President of Cboe Europe Howson hold a conference call to discuss the acquisition of EuroCCP on July 2 at 8:30 am. Webcast Link

ShowHide Related Items >><<
CBOE Cboe Global Markets
$96.41 /

+3.34 (+3.59%)

CBOE Cboe Global Markets
$96.41 /

+3.34 (+3.59%)

06/23/20
Fly Intel: Top five analyst downgrades
06/23/20 Goldman Sachs
Cboe Global Markets downgraded to Sell from Neutral at Goldman Sachs
06/10/20 BofA
HFCAA could primarily impact Nasdaq, IntercontinentalExchange, says BofA
06/02/20
Fly Intel: Top five analyst downgrades
CBOE Cboe Global Markets
$96.41 /

+3.34 (+3.59%)

CBOE Cboe Global Markets
$96.41 /

+3.34 (+3.59%)

CBOE Cboe Global Markets
$96.41 /

+3.34 (+3.59%)

CBOE Cboe Global Markets
$96.41 /

+3.34 (+3.59%)

Recommendations
Constellation Brands price target raised to $227 from $200 at JPMorgan » 08:24
07/02/20
07/02
08:24
07/02/20
08:24
STZ

Constellation Brands

$185.60 /

+11.17 (+6.40%)

JPMorgan analyst Andrea…

JPMorgan analyst Andrea Teixeira raised the firm's price target on Constellation Brands to $227 from $200 and keeps an Overweight rating on the shares following the company's better than expected Q1 results. The analyst remains confident Constellation will continue to gain share in the total beverage alcohol industry and believes the stock can continue to outperform as investors begin to refocus on the company's "strong underlying algorithm."

ShowHide Related Items >><<
STZ Constellation Brands
$185.60 /

+11.17 (+6.40%)

STZ Constellation Brands
$185.60 /

+11.17 (+6.40%)

07/02/20 Credit Suisse
Constellation Brands price target raised to $215 from $205 at Credit Suisse
07/02/20 Deutsche Bank
Constellation Brands price target raised to $185 from $176 at Deutsche Bank
07/02/20 UBS
Constellation Brands price target raised to $208 from $192 at UBS
07/02/20 Jefferies
Constellation Brands price target raised to $238 from $224 at Jefferies
STZ Constellation Brands
$185.60 /

+11.17 (+6.40%)

STZ Constellation Brands
$185.60 /

+11.17 (+6.40%)

STZ Constellation Brands
$185.60 /

+11.17 (+6.40%)

STZ Constellation Brands
$185.60 /

+11.17 (+6.40%)

Technical Analysis
DJ Transportation Average: Pivot points » 08:24
07/02/20
07/02
08:24
07/02/20
08:24
$DJT

DJ Transportation Average

$0.00 /

+ (+0.00%)

The following are the…

The following are the pivot points for the DJ Transportation Average ($DJT). Pivot High: 9327.02, Pivot Low: 8956.57. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

ShowHide Related Items >><<
$DJT DJ Transportation Average
$0.00 /

+ (+0.00%)

$DJT DJ Transportation Average
$0.00 /

+ (+0.00%)

Technical Analysis
DJ Utility Average: Pivot points » 08:24
07/02/20
07/02
08:24
07/02/20
08:24
$DJU

DJ Utility Average

$0.00 /

+ (+0.00%)

The following are the…

The following are the pivot points for the DJ Utility Average ($DJU). Pivot High: 797.585, Pivot Low: 776.045. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

ShowHide Related Items >><<
$DJU DJ Utility Average
$0.00 /

+ (+0.00%)

Technical Analysis
Dow Jones Industrial Average: Pivot points » 08:24
07/02/20
07/02
08:24
07/02/20
08:24
DJX

Dow Jones Industrial Average

$0.00 /

+ (+0.00%)

The following are the…

The following are the pivot points for the Dow Jones Industrial Average (DJX). Pivot High: 25877.14, Pivot Low: 25571.44. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

ShowHide Related Items >><<
DJX Dow Jones Industrial Average
$0.00 /

+ (+0.00%)

DJX Dow Jones Industrial Average
$0.00 /

+ (+0.00%)

02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
DJX Dow Jones Industrial Average
$0.00 /

+ (+0.00%)

DJX Dow Jones Industrial Average
$0.00 /

+ (+0.00%)

Technical Analysis
iShares Transportation Average: Pivot points » 08:24
07/02/20
07/02
08:24
07/02/20
08:24
IYT

iShares Transportation Average

$162.17 /

-0.68 (-0.42%)

The following are the…

The following are the pivot points for the iShares Transportation Average (IYT). Pivot High: $165.259, Pivot Low: $158.761. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

ShowHide Related Items >><<
IYT iShares Transportation Average
$162.17 /

-0.68 (-0.42%)

IYT iShares Transportation Average
$162.17 /

-0.68 (-0.42%)

IYT iShares Transportation Average
$162.17 /

-0.68 (-0.42%)

Technical Analysis
Technology Select Sector SPDR: Pivot points » 08:23
07/02/20
07/02
08:23
07/02/20
08:23
XLK

Technology Select Sector SPDR

$104.69 /

+0.13 (+0.12%)

The following are the…

The following are the pivot points for the Technology Select Sector SPDR (XLK). Pivot High: $105.542, Pivot Low: $104.398. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

ShowHide Related Items >><<
XLK Technology Select Sector SPDR
$104.69 /

+0.13 (+0.12%)

06/10/20 Jefferies
Jefferies downgrades Tech sector to Market Weight from Overweight
XLK Technology Select Sector SPDR
$104.69 /

+0.13 (+0.12%)

XLK Technology Select Sector SPDR
$104.69 /

+0.13 (+0.12%)

Technical Analysis
Energy Select Sector SPDR: Pivot points » 08:23
07/02/20
07/02
08:23
07/02/20
08:23
XLE

Energy Select Sector SPDR

$36.90 /

-0.93 (-2.46%)

The following are the…

The following are the pivot points for the Energy Select Sector SPDR (XLE). Pivot High: $37.724, Pivot Low: $36.092. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

ShowHide Related Items >><<
XLE Energy Select Sector SPDR
$36.90 /

-0.93 (-2.46%)

XLE Energy Select Sector SPDR
$36.90 /

-0.93 (-2.46%)

XLE Energy Select Sector SPDR
$36.90 /

-0.93 (-2.46%)

XLE Energy Select Sector SPDR
$36.90 /

-0.93 (-2.46%)

Hot Stocks
Full House Resorts appoints Eric Green, Michael Shaunnessy to board » 08:23
07/02/20
07/02
08:23
07/02/20
08:23
FLL

Full House Resorts

$1.51 /

+0.165 (+12.31%)

Full House Resorts…

Full House Resorts announced that it has appointed Eric Green and Michael Shaunnessy to the Company's board of directors. Green currently serves as Penn Capital's chief investment officer of Equity, where he is responsible for guiding the firm's equity strategies. Most recently, Mr. Shaunnessy was President and CEO of Nevada Gold & Casinos, Inc., which he led for more than six years until its sale in 2019.

ShowHide Related Items >><<
FLL Full House Resorts
$1.51 /

+0.165 (+12.31%)

FLL Full House Resorts
$1.51 /

+0.165 (+12.31%)

05/14/20 Roth Capital
Full House Resorts 'significantly undervalued,' says Roth Capital
11/04/19 Macquarie
Full House Resorts upgraded to Outperform from Neutral at Macquarie
FLL Full House Resorts
$1.51 /

+0.165 (+12.31%)

Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points » 08:23
07/02/20
07/02
08:23
07/02/20
08:23
XLY

Consumer Discretionary Sector SPDR

$129.06 /

+1.28 (+1.00%)

The following are the…

The following are the pivot points for the Consumer Discretionary Sector SPDR (XLY). Pivot High: $130.137, Pivot Low: $128.401. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

ShowHide Related Items >><<
XLY Consumer Discretionary Sector SPDR
$129.06 /

+1.28 (+1.00%)

03/18/20
Jefferies ups Health Care to Overweight, cuts Discretionary to Underweight
XLY Consumer Discretionary Sector SPDR
$129.06 /

+1.28 (+1.00%)

Hot Stocks
Kendall sees potential value inflection points coming for Aquestive shareholders » 08:23
07/02/20
07/02
08:23
07/02/20
08:23
AQST

Aquestive Therapeutics

$4.75 /

-0.11 (-2.26%)

Aquestive Therapeutics…

Aquestive Therapeutics (AQST) is a pharmaceutical company committed to developing and commercializing products to address unmet medical needs. In an exclusive interview with The Fly, Aquestive President and CEO Keith Kendall discussed the company's business and cash position: "There are several things that are important to understand about our business. First, Aquestive has a proven track record of success in developing and manufacturing differentiated therapeutics with PharmFilm technology. We have five FDA approved therapeutics, both licensed and proprietary products. Second, we launched our first self-commercialized proprietary product, Sympazan, for the treatment of Lennox-Gastaut Syndrome in December 2018. Sympazan continues to grow and penetrate the market in which many prescribers will also be prescribers of Libervant when it is approved. Third, we continue to advance our late-stage pipeline of therapeutics for complex conditions. Libervant is the most advanced candidate in our pipeline, and, while there can be no assurances as to the decision the FDA may make, we hope to see it approved in September. Lastly, AQST-108, which could be the "first of its kind" oral version of epinephrine, will continue on its 505(b)(2) clinical and regulatory pathway following our recent IND filing with the FDA. We expect PK trials to begin later this year. Through a combination of our revenue, cash on hand and monetizable assets, we believe that we have capital or visibility to capital that will enable us to fund our business well into 2021 and possibly beyond. These, combined with some licensee activities, present a significant number of potential value inflection points for shareholders over the coming 12-24 months." "Meet the Company" is The Fly's recurring series of exclusive short interviews with Executive Officers to offer a deeper look inside the company. The remainder of this interview to follow.

ShowHide Related Items >><<
AQST Aquestive Therapeutics
$4.75 /

-0.11 (-2.26%)

AQST Aquestive Therapeutics
$4.75 /

-0.11 (-2.26%)

05/22/20 H.C. Wainwright
Aquestive Therapeutics price target raised to $15 from $13 at H.C. Wainwright
03/16/20 Wedbush
Aquestive Therapeutics price target lowered to $31 from $36 at Wedbush
02/10/20 Wedbush
Wedbush delays launch estimates for Libervant, ups Aquestive Therapeutics target
02/10/20 Wedbush
Aquestive price target raised to $36 at Wedbush after FDA accepts NDA
AQST Aquestive Therapeutics
$4.75 /

-0.11 (-2.26%)

  • 13
    Dec
AQST Aquestive Therapeutics
$4.75 /

-0.11 (-2.26%)

AQST Aquestive Therapeutics
$4.75 /

-0.11 (-2.26%)

Technical Analysis
S&P Select Materials SPDR: Pivot points » 08:23
07/02/20
07/02
08:23
07/02/20
08:23
XLB

S&P Select Materials SPDR

$56.50 /

+0.14 (+0.25%)

The following are the…

The following are the pivot points for the S&P Select Materials SPDR (XLB). Pivot High: $57.027, Pivot Low: $56.098. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

ShowHide Related Items >><<
XLB S&P Select Materials SPDR
$56.50 /

+0.14 (+0.25%)

06/10/20 Jefferies
Jefferies downgrades Tech sector to Market Weight from Overweight
XLB S&P Select Materials SPDR
$56.50 /

+0.14 (+0.25%)

XLB S&P Select Materials SPDR
$56.50 /

+0.14 (+0.25%)

Technical Analysis
Utilities SPDR: Pivot points » 08:22
07/02/20
07/02
08:22
07/02/20
08:22
XLU

Utilities SPDR

$57.75 /

+1.3 (+2.30%)

The following are the…

The following are the pivot points for the Utilities SPDR (XLU). Pivot High: $58.653, Pivot Low: $57.102. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

ShowHide Related Items >><<
XLU Utilities SPDR
$57.75 /

+1.3 (+2.30%)

01/15/20 Goldman Sachs
Avangrid downgraded to Sell from Neutral at Goldman Sachs
XLU Utilities SPDR
$57.75 /

+1.3 (+2.30%)

XLU Utilities SPDR
$57.75 /

+1.3 (+2.30%)

Downgrade
FormFactor downgraded to Hold from Buy at Craig-Hallum » 08:22
07/02/20
07/02
08:22
07/02/20
08:22
FORM

FormFactor

$29.34 /

+0.01 (+0.03%)

Craig-Hallum analyst…

Craig-Hallum analyst Christian Schwab downgraded FormFactor to Hold from Buy with a price target of $29, up from $25.

ShowHide Related Items >><<
FORM FormFactor
$29.34 /

+0.01 (+0.03%)

FORM FormFactor
$29.34 /

+0.01 (+0.03%)

07/02/20 Stifel
FormFactor price target raised to $35 after positive pre-announcement at Stifel
06/18/20 B. Riley FBR
FormFactor price target raised to $36 from $30 at B. Riley FBR
06/15/20 Stifel
FormFactor upgraded to Buy from Hold at Stifel
06/01/20 DA Davidson
FormFactor upgraded to Buy from Neutral at DA Davidson
FORM FormFactor
$29.34 /

+0.01 (+0.03%)

FORM FormFactor
$29.34 /

+0.01 (+0.03%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.